2006
DOI: 10.1016/j.jaut.2006.08.003
|View full text |Cite
|
Sign up to set email alerts
|

The impact of abnormal autoimmune function on reproduction: Maternal and fetal consequences

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 21 publications
0
19
0
Order By: Relevance
“…There are autoimmune diseases that can have an adverse effect on pregnancy and perinatal outcome, including recurrent spontaneous miscarriages, premature deliveries, and perinatal mortality [7][8][9]. Systemic lupus erythematosus (SLE) is association with perinatal morbidity and mortality [10].…”
Section: Introductionmentioning
confidence: 99%
“…There are autoimmune diseases that can have an adverse effect on pregnancy and perinatal outcome, including recurrent spontaneous miscarriages, premature deliveries, and perinatal mortality [7][8][9]. Systemic lupus erythematosus (SLE) is association with perinatal morbidity and mortality [10].…”
Section: Introductionmentioning
confidence: 99%
“…That reporting biases can also interact with each other is demonstrated by the decrease in miscarriage rates over recent years in women with SLE [28] and with autoimmune diseases in general [32], both very likely results of increasingly successful preconception counseling and therapeutic interventions. All of this, therefore, suggests that associations between autoimmune function and premature labor have to be considered strongly biased against such a finding.…”
Section: Difficulties In Evaluating Associations Between Ptd and (Autmentioning
confidence: 99%
“…In recurrent pregnancy losses, aPL, antiprothrombin, and antisaccharomycetes cerevisiae antibodies were more prevalent than in controls, with odd ratio of 4.8, 5.4, and 3.9 for each antibody, respectively. Therefore, although there is a general consensus to screen for aPL in patients with recurrent pregnancy losses, larger cohort studies are necessary to determine the true incidence of recurrent pregnancy losses in the presence of other autoantibody or combinations of autoantibodies [51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66]. In addition, these cohort studies should either be corrected for the subsequent miscarriages caused by fetal chromosomal aberrations, or use multivariate analysis to corect for the effect of confounding factors such as maternal age.…”
Section: Other Autoantibodies and Recurrent Pregnancy Lossesmentioning
confidence: 99%